Simplex Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-6,820
Closed -$20K 7120
2016
Q3
$20K Buy
6,820
+6,015
+747% +$10.4K ﹤0.01% 3005
2016
Q2
$1K Sell
805
-5,170
-87% -$11.8K ﹤0.01% 5640
2016
Q1
$22K Sell
5,975
-7,142
-54% -$44.2K ﹤0.01% 2741
2015
Q4
$132K Buy
+13,117
New +$158K 0.01% 1150
2015
Q2
Sell
-1,028
Closed -$22.2K 6344
2015
Q1
$26K Sell
1,028
-13,681
-93% -$348K ﹤0.01% 2127
2014
Q4
$308K Buy
+14,709
New +$371K 0.04% 420

Simplex Trading's AEGR Position: Q4 2016 in Review

Simplex Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 6,820 shares — an estimated $20K sold.

Simplex Trading first reported a position in AEGR in Q4 2014 and held it in 6 quarters. The position peaked at $308K in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Simplex Trading reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Simplex Trading sold 6,820 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $20K.
  • Simplex Trading first reported a position in Aegerion Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • Simplex Trading's Aegerion Pharmaceuticals position peaked at $308K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.